The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Researchers say they've developed a urine test that could answer whether prostate cancer is aggressive and requiring immediate treatment, or slow-growing and worthy ...

The UK National Screening Committee said there were more harms than benefits to using the PSA test for screening all men.

A new blood test for prostate cancer that offers greater accuracy than prostate-specific antigen (PSA) has been put to the test by researchers at the University of East Anglia (UEA) in collaboration ...